FR / EN / 中文 / 日本語
Delivering Health and Beauty ©
Since AXIALYS delivery systems are based on highly biocompatible molecules able to provide slow, controlled release of the carried ingredients, we consider that our delivery systems can be deployed in the pharmaceutical industry.

AXIALYS pharmaceutical research will focus on Dermatology:
Drug delivery: enhancing benefits of proven actives using our delivery technologies. Our first product target the reduction of the cytotoxicity of Hydroquinone.
Injectable filler: Class III medical device, intended for dermatologists and indicated for injection into the mid to deep dermis for correction of moderate to severe facial wrinkles and folds.

To optimize our R&D investment and maintain our independence, AXIALYS use the profit generated from the ‘faster to market’ nutraceuticals and cosmeceutical business, to fund new promising pharmaceutical opportunities.

The route to market for AXIALYS health care products is through partnering with a larger pharmaceutical company at the appropriate stage in a product’s development.

Copyright 2010 © AXIALYS Innovations. All rights reserved. | Disclaimer